BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 15690140)

  • 21. Postoperative radiotherapy of primary spinal cord tumors.
    Linstadt DE; Wara WM; Leibel SA; Gutin PH; Wilson CB; Sheline GE
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1397-403. PubMed ID: 2542194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
    Kukreja S; Ambekar S; Sin AH; Nanda A
    J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and surgical outcomes of spinal myxopapillary ependymomas.
    Liu T; Yang C; Deng X; Li A; Xin Y; Yang J; Xu Y
    Neurosurg Rev; 2020 Oct; 43(5):1351-1356. PubMed ID: 31473875
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spinal myxopapillary ependymoma: neurological deterioration in patients treated with surgery.
    Sakai Y; Matsuyama Y; Katayama Y; Imagama S; Ito Z; Wakao N; Kanemura T; Yoshida G; Sato K; Ando T; Nakamura H; Kato F; Yukawa Y; Ito K; Ishiguro N
    Spine (Phila Pa 1976); 2009 Jul; 34(15):1619-24. PubMed ID: 19564773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
    Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
    J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant radiotherapy in the treatment of pediatric myxopapillary ependymomas.
    Al-Halabi H; Montes JL; Atkinson J; Farmer JP; Freeman CR
    Pediatr Blood Cancer; 2010 Oct; 55(4):639-43. PubMed ID: 20806362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal cord ependymomas in adults: analysis of 15 cases.
    Kocak Z; Garipagaoglu M; Adli M; Uzal MC; Kurtman C
    J Exp Clin Cancer Res; 2004 Jun; 23(2):201-6. PubMed ID: 15354403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remarkable efficacy of temozolomide for relapsed spinal myxopapillary ependymoma with multiple recurrence and cerebrospinal dissemination: a case report and literature review.
    Fujiwara Y; Manabe H; Izumi B; Shima T; Adachi N
    Eur Spine J; 2018 Jul; 27(Suppl 3):421-425. PubMed ID: 29270703
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical outcomes of spinal cord and cauda equina ependymoma: Postoperative motor status and recurrence for each WHO grade in a multicenter study.
    Kobayashi K; Ando K; Kato F; Kanemura T; Sato K; Kamiya M; Nishida Y; Ishiguro N; Imagama S
    J Orthop Sci; 2018 Jul; 23(4):614-621. PubMed ID: 29610008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spinal myxopapillary ependymoma outcomes in patients treated with surgery and radiotherapy at M.D. Anderson Cancer Center.
    Akyurek S; Chang EL; Yu TK; Little D; Allen PK; McCutcheon I; Mahajan A; Maor MH; Woo SY
    J Neurooncol; 2006 Nov; 80(2):177-83. PubMed ID: 16648988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimising treatment strategies in spinal ependymoma based on 20years of experience at a single centre.
    Keil VC; Schmitt AJ; Martin SC; Cadoux-Hudson TA; Pereira EA
    J Clin Neurosci; 2016 Jul; 29():52-8. PubMed ID: 26944215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The results of radiotherapy for ependymomas: the Mayo Clinic experience.
    Schild SE; Nisi K; Scheithauer BW; Wong WW; Lyons MK; Schomberg PJ; Shaw EG
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):953-8. PubMed ID: 9869215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome predictors in the management of spinal cord ependymoma.
    Gavin Quigley D; Farooqi N; Pigott TJ; Findlay GF; Pillay R; Buxton N; Jenkinson MD
    Eur Spine J; 2007 Mar; 16(3):399-404. PubMed ID: 16865377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary intramedullary ependymomas: retrospective study of 16 cases].
    Kochbati L; Nasr C; Frikha H; Gargouri W; Benna F; Besbes M; Daoud J; Bouaouina N; Ben Abdallah M; Maalej M
    Cancer Radiother; 2003 Feb; 7(1):17-21. PubMed ID: 12648713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of pediatric Grade II spinal ependymomas: a population-based study.
    Lin Y; Jea A; Melkonian SC; Lam S
    J Neurosurg Pediatr; 2015 Mar; 15(3):243-9. PubMed ID: 25525932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spinal ependymomas. Part 1: Intramedullary ependymomas.
    Klekamp J
    Neurosurg Focus; 2015 Aug; 39(2):E6. PubMed ID: 26235023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spinal cord ependymoma: radical surgical resection and outcome.
    Hanbali F; Fourney DR; Marmor E; Suki D; Rhines LD; Weinberg JS; McCutcheon IE; Suk I; Gokaslan ZL
    Neurosurgery; 2002 Nov; 51(5):1162-72; discussion 1172-4. PubMed ID: 12383361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome predictors in the management of spinal myxopapillary ependymoma: an integrative survival analysis.
    Kukreja S; Ambekar S; Sharma M; Sin AH; Nanda A
    World Neurosurg; 2015 May; 83(5):852-9. PubMed ID: 25108296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinal cord gliomas: management and outcome with reference to adjuvant therapy.
    Nishio S; Morioka T; Fujii K; Inamura T; Fukui M
    J Clin Neurosci; 2000 Jan; 7(1):20-3. PubMed ID: 10847645
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative management of primary spinal cord ependymomas.
    Di Marco A; Griso C; Pradella R; Campostrini F; Garusi GF
    Acta Oncol; 1988; 27(4):371-5. PubMed ID: 3202994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.